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after many years of “standard” aortic valve replacement,
surgeons are revisiting other approaches, including aor-
ic valve repair (including valve-sparing techniques), differ-
nt prostheses, and apical–aortic conduits. Dr. Sundt has
rranged for two groups with significant experience with
pical–aortic conduits to present the “off-pump” and “on-
ump” approaches. Tetralogy of Fallot with pulmonary atre-
ia and major aortopulmonary collaterals is a daunting lesion
or even the most experienced congenital heart surgeon. Dr.
radley has put together alternative approaches to this diffi-
ult lesion from two highly experienced groups. Lung vol-
me reduction surgery is gradually developing a place in the
horacic surgeons’ armamentarium. Outcomes remain highly
ependent on patient selection and technical aspects of the
rocedure. Dr. Jones has developed a description of very
ifferent approaches—median sternotomy in one case and a
horacoscopic approach in the other. We hope our readers
ill enjoy the descriptions of alternate approaches to these
hree problems.
ercutaneous
ortic Valve Prostheses
ecent progress in the development of percutaneous aortic
alve prostheses has refocused surgeons’ attention to alterna-
ive techniques for relief of aortic valvular stenosis. The use of
pical–aortic conduits was introduced in 1965 by Bernhard
nd was rapidly adopted by surgeons interested in congenital
eart disease for the management of complex aortic valve and
scending aortic pathologies. Dr. John Brown has been a
ioneer in this area, having published numerous articles on
he use of apical–aortic conduits over the past 30 years. He
as developed an approach for conducting the procedure
ithout the use of cardiopulmonary bypass, which is most
ntriguing and may be of particular value in elderly patients
ith extensive peripheral atherosclerotic disease as well as in
he pediatric population in which Dr. Brown’s principal ex-
erience resides. Dr. Kenton Zehr has also published the
ayo Clinic experience with apical–aortic conduits, princi-
ally in the adult population. Dr. Zehr has emphasized the
alue of apical–aortic conduits for acquired aortic stenosis in
atients with a hostile mediastinum due either to multiple
oronary grafts or to severely calcified ascending aorta. As
uch, it may be a competing technology for percutaneous
alve procedures. a
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oi:10.1053/j.optechstcvs.2007.05.002We believe the readers will enjoy comparing and contrast-
ng these two approaches to the construction of the apical–
ortic conduit and hope that they will find value from them in
heir clinical practice.
etralogy of Fallot with
ulmonary Atresia and
ajor Aortopulmonary
ollateral Arteries
etralogy of Fallot with pulmonary atresia and major aorto-
ulmonary collateral arteries is one of the most complex le-
ions confronting congenital heart surgeons. The goal of sur-
ical therapy is to create separate pulmonary and systemic
irculations with the lowest possible right ventricular pres-
ure. The variability of the central and collateral pulmonary
irculation mandates flexibility in approach, which may in-
lude single-stage repair or staged unifocalizations in appro-
riate patients. Further challenges include the decision of
hether to close the ventricular septal defect, the effective
oordination between surgeons and interventional cardi-
logists, and the use of newer imaging modalities, such as
omputed tomography angiography. Dr. Lofland from
ansas City illustrates his decision algorithm and ap-
roach to single-stage unifocalization via a median ster-
otomy. For comparison, Dr. Kurosawa from Tokyo pre-
ents a case series of staged unifocalizations through
horacotomies including innovative approaches such as
he use of the azygos vein as a conduit.
ung Volume Reduction Surgery
ew operations in general thoracic surgery have generated as
uch controversy as lung volume reduction surgery (LVRS).
lthough LVRS was initially reported in 1959 by Brantigan
nd colleagues, Joel Cooper and colleagues at Washington
niversity subsequently re-introduced it with their seminal
eport in 1996. Much of the controversy regarding the oper-
tion has dealt with patient selection criteria, comparisons to
est medical care in the National Emphysema Treatment
rial, and cost–benefit analyses. Additionally, most thoracic
urgeons who have performed a significant number of these
rocedures realize that the conduct of this operation is usu-
lly rather straightforward. There are, however, important
nd sparingly described technical considerations for the ma-
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74 F.A. Crawfordority of thoracic surgeons who have limited experience with
his operation. In this issue, Dr. Joel Cooper describes his
pproach for a LVRS through a median sternotomy, whereas
r. Robert McKenna, one of the pioneers in thoracoscopic
urgery, describes his approach for thoracoscopic LVRS. Not
ithstanding the choice of the incision, the similarity of both
pproaches is obvious with the adherence to the operative
rinciples necessary for a successful outcome described byoth authors. Given that this operation will be performed for
any years to come, these two technical reports will most
ertainly be read and reviewed by both current and future
horacic surgeons interested in the surgical treatment of end-
tage lung disease.
Fred A. Crawford, Jr, MD
Editor
